Ivabradine MR CAD (Completed)

Study: CL3-16257-097, a randomised, double-blind, parallel groups, multicentre trial. Safety of oral chronic administration of ivabradine MRcompared to ivabradine immediate release formulation, in patients with stable coronary artery disease.